11 August 2020 2 Min Read
J&J aims to have results of Covid-19 vaccine’s efficacy by end-2020 to mid-2021
Once a vaccine has been developed, J & may consider injecting healthy volunteers with Covid-19 if there are not enough patients for final trials, a company executive says
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In